StonvexLoading…
StonvexStonvexStonvexCore line items from BCAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $225.98M | $179.80M | $123.52M | $93.58M |
Operating Income | $87.96M | $8.26M | $36.86M | $21.98M |
Net Income | $63.06M | $5.43M | $25.91M | $16.11M |
EPS (Diluted) | $1.93 | $0.22 | $1.39 | $0.88 |
Total Assets | $4.03B | $4.03B | $2.36B | $2.28B |
Total Liabilities | $3.46B | $3.52B | $2.07B | $2.02B |
Cash & Equivalents | $399.91M | $388.16M | $86.79M | $86.76M |
Free Cash Flow OCF − CapEx | $56.94M | $49.74M | $32.80M | $12.27M |
Shares Outstanding | 32.42M | 32.27M | 18.37M | 17.94M |